Michelle Long | Profiles RNS

Michelle T. Long, MD, MSc

Assistant Professor

Boston Medical Center

Dept of Medicine

Gastroenterology

MD, Tufts University School of Medicine

Pronouns: she/her/hers

Websites

	Boston Medical Center Provider Profile
	ResearchGate

ORCID : 0000-0001-6131-3981

Michelle T. Long, MD, MSc is a physician-scientist with an expertise in Nonalcoholic fatty liver disease (NAFLD), and Assistant Professor of Medicine at Boston University. She completed her clinical training at Massachusetts General Hospital and Boston Medical Center. Dr. Long is the Director of the NAFLD Research Center and the Director of Clinical Research for the Section of Gastroenterology and Hepatology. Her clinical and research interests center on the relationship between NAFLD and cardiovascular disease. Dr. Long is primarily interested in patient-oriented research investigating fibrosis and inflammation in patients with NAFLD and in imaging and risk stratification strategies for hepatic fibrosis. Dr. Long has projects at Boston Medical Center and at the Framingham Heart Study where she is the PI of a study evaluating the prevalence and risk factors for liver fat (steatosis) and fibrosis. In Framingham, she is investigating the clinical and genetic correlates of hepatic steatosis and fibrosis as measured by transient elastography. Dr. Long receives research funding from the NIH (NIDDK), Doris Duke Charitable Foundation, Gilead Sciences, Echosens Corporation, and Boston University. She has expertise in epidemiology, visceral fat, liver imaging including computed tomography, ultrasound, and transient elastography. Dr. Long is also a clinical hepatologist and endoscopist.

Dr. Long is additionally interested in novel therapeutics for NAFLD and Non-alcoholic steatohepatitis (NASH) and runs the clinical trials program for the NAFLD Research Center.

Her other research interests include alcohol-related liver disease, hepatitis C, outcomes in end-stage liver disease/cirrhosis.

Investigator
Framingham Heart Study

Member
Boston University
Evans Center for Interdisciplinary Biomedical Research

Full Member
Boston University Medical Center
Boston Nutrition Obesity Research Center

2020 Boston University School of Medicine: Resident Research Mentor Award

2019 NASH TAG Conference: Emerging Leader in NAFLD

2016 Boston University School of Medicine: Women's Leadership Conference Selected Participant

2016 Boston University School of Medicine: Faculty Development and Diversity Grant Recipient

2015-2020 Boston University School of Medicine: NIH Loan Repayment Program Recipient

2014 Boston University School of Medicine: 3rd Place, Evans Research Day

2009 Tufts University School of Medicine: Massachusetts Medical Society Scholars Award

2009 Tufts University School of Medicine: Glasgow-Rubin Citation for Academic Achievement

2009 Tufts University School of Medicine: Phi Delta Epsilon Fraternity Award

2009 Tufts University School of Medicine: Alpha Omega Alpha

2008 Tufts University School of Medicine: Magna cum laude Scientific electronic exhibit award

2008 Tufts University School of Medicine: Ada Draper, MD Scholarship

2006-2007 Tufts University School of Medicine: Boston Albert Schweitzer Fellowship

2006-2008 Tufts University School of Medicine: USA Funds Scholarship

2004 Middlebury College: Magna cum laude

Resting metabolic signature of non-alcoholic fatty liver disease and the metabolic response to acute exercise in a community based sample
07/01/2019 - 06/30/2022 (PI)
Doris Duke Charitable Foundation

Prevalence and risk factors for hepatic steatosis and fibrosis as measured by transient elastography
03/15/2016 - 05/31/2019 (PI)
Echosens

Identifying clinical and genetic correlates of hepatic fibrosis from fatty liver disease in the…
01/12/2018 - 11/30/2022 (PI)
NIH-NIDDK
5K23DK113252-03

AURORA: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study
07/01/2019 - 07/31/2022 (PI)
Allergan Sales, LLC

MB130-068
12/06/2018 - 12/06/2021 (PI)
Bristol-Myers

MB130-069
12/06/2018 - 12/06/2021 (PI)
Bristol-Myers

Determining the burden, heritability, and clinical implications of increased liver stiffness from…
01/02/2019 - 01/01/2021 (PI)
Gilead Sciences

A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled, Multicenter Study Evaluating …
05/16/2017 - 05/16/2020 (PI)
Intercept Pharmaceuticals, Inc.

A Double-Blind, Placebo-Controlled Trial of Obeticholic Acid in Patients with moderately severe A…
10/06/2016 - 10/05/2018 (PI)
Indiana University NIH-NIAAA
4U01AA021840-05

Title

Yr	Title	Project-Sub Proj	Pubs
2020	Identifying clinical and genetic correlates of hepatic fibrosis from fatty liver disease in the community	5K23DK113252-03	15
2019	Identifying clinical and genetic correlates of hepatic fibrosis from fatty liver disease in the community	5K23DK113252-02	15
2018	Identifying clinical and genetic correlates of hepatic fibrosis from fatty liver disease in the community	1K23DK113252-01A1	15

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Long MT, Zhang X, Xu H, Liu CT, Corey KE, Chung RT, Loomba R, Benjamin EJ. Hepatic fibrosis associates with multiple cardiometabolic disease risk factors: The Framingham Heart Study. Hepatology. 2020 Oct 30.View Related Profiles.

Liu, Ching-Ti
Benjamin, Emelia
Long, Michelle

PMID: 33125745

Bianco C, Romeo S, Petta S, Long MT, Valenti L. MAFLD vs NAFLD: Let the contest begin! Liver Int. 2020 09; 40(9):2079-2081. PMID: 32930521

Chiu LS, Pedley A, Massaro JM, Benjamin EJ, Mitchell GF, McManus DD, Aragam J, Vasan RS, Cheng S, Long MT. The association of non-alcoholic fatty liver disease and cardiac structure and function-Framingham Heart Study. Liver Int. 2020 Oct; 40(10):2445-2454.View Related Profiles.

Benjamin, Emelia
Massaro, Joseph
Long, Michelle

PMID: 32654390

Long MT, Gandhi S, Loomba R. Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease. Metabolism. 2020 10; 111S:154259. PMID: 32387227

Brunner KT, Pedley A, Massaro JM, Hoffmann U, Benjamin EJ, Long MT. Increasing liver fat is associated with progression of cardiovascular risk factors. Liver Int. 2020 06; 40(6):1339-1343.View Related Profiles.

Benjamin, Emelia
Massaro, Joseph
Long, Michelle

PMID: 32301571

Fricker ZP, Mukthinuthalapati VVPK, Akinyeye S, Chalasani N, Attar BM, Balakrishnan M, Ghabril M, Long MT. MELD-Na Is More Strongly Associated with Risk of Infection and Outcomes Than Other Characteristics of Patients with Cirrhosis. Dig Dis Sci. 2020 Feb 25.View Related Profiles.

Long, Michelle
Fricker, Zachary

PMID: 32100160

So-Armah KA, Lim JK, Lo Re V, Tate JP, Chang CH, Butt AA, Gibert CL, Rimland D, Marconi VC, Goetz MB, Ramachandran V, Brittain E, Long M, Nguyen KL, Rodriguez-Barradas MC, Budoff MJ, Tindle HA, Samet JH, Justice AC, Freiberg MS. FIB-4 stage of liver fibrosis is associated with incident heart failure with preserved, but not reduced, ejection fraction among people with and without HIV or hepatitis C. Prog Cardiovasc Dis. 2020 Mar - Apr; 63(2):184-191.View Related Profiles.

Samet, Jeffrey
So-Armah, Kaku
Long, Michelle
Ramachandran, Vasan

PMID: 32068085

Long MT, Naimi TS. Reply. Clin Gastroenterol Hepatol. 2020 Jun; 18(7):1651-1652.View Related Profiles.

Long, Michelle
Naimi, Timothy

PMID: 31926338

Long MT, Massaro JM, Hoffmann U, Benjamin EJ, Naimi TS. Alcohol Use Is Associated With Hepatic Steatosis Among Persons With Presumed Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2020 Jul; 18(8):1831-1841.e5.View Related Profiles.

Benjamin, Emelia
Massaro, Joseph
Long, Michelle
Naimi, Timothy

PMID: 31734449

Soni K, Fricker Z, Long MT. Pyogenic liver abscesses from Fusobacterium nucleatum in an immunocompetent host. Clin Res Hepatol Gastroenterol. 2020 06; 44(3):e59-e60.View Related Profiles.

Long, Michelle
Fricker, Zachary

PMID: 31607642

Showing 10 of 49 results. Show More

Brunner KT, Henneberg CJ, Wilechansky RM, Long MT. Nonalcoholic Fatty Liver Disease and Obesity Treatment. Curr Obes Rep. 2019 Sep; 8(3):220-228.View Related Profiles.

Long, Michelle
Wilechansky, Robert

PMID: 30945129

Brunner KT, Pedley A, Massaro JM, Hoffmann U, Benjamin EJ, Long MT. Increasing Liver Fat Is Associated With Incident Cardiovascular Risk Factors. Clin Gastroenterol Hepatol. 2020 Jul; 18(8):1884-1886.View Related Profiles.

Benjamin, Emelia
Massaro, Joseph
Long, Michelle

PMID: 31404666

Chen VL, Wright AP, Halligan B, Chen Y, Du X, Handelman SK, Long MT, Kiel DP, Speliotes EK. Body Composition and Genetic Lipodystrophy Risk Score Associate With Nonalcoholic Fatty Liver Disease and Liver Fibrosis. Hepatol Commun. 2019 Aug; 3(8):1073-1084. PMID: 31388628

Wilechansky RM, Pedley A, Massaro JM, Hoffmann U, Benjamin EJ, Long MT. Relations of liver fat with prevalent and incident chronic kidney disease in the Framingham Heart Study: A secondary analysis. Liver Int. 2019 08; 39(8):1535-1544.View Related Profiles.

Benjamin, Emelia
Massaro, Joseph
Long, Michelle
Wilechansky, Robert

PMID: 31033142

Pratt PK, Nunes D, Long MT, Farraye FA. Improved Antibody Response to Three Additional Hepatitis B Vaccine Doses Following Primary Vaccination Failure in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2019 07; 64(7):2031-2038.View Related Profiles.

Nunes, David
Farraye, Francis
Long, Michelle

PMID: 30945037

Long MT, Ko D, Arnold LM, Trinquart L, Sherer JA, Keppel SS, Benjamin EJ, Helm RH. Gastrointestinal and liver diseases and atrial fibrillation: a review of the literature. Therap Adv Gastroenterol. 2019; 12:1756284819832237.View Related Profiles.

Ko, Darae
Benjamin, Emelia
Sherer, Jason
Trinquart, Ludovic
Long, Michelle
Helm, Robert

PMID: 30984290

Ma J, Nano J, Ding J, Zheng Y, Hennein R, Liu C, Speliotes EK, Huan T, Song C, Mendelson MM, Joehanes R, Long MT, Liang L, Smith JA, Reynolds LM, Ghanbari M, Muka T, van Meurs JBJ, Alferink LJM, Franco OH, Dehghan A, Ratliff S, Zhao W, Bielak L, Kardia SLR, Peyser PA, Ning H, VanWagner LB, Lloyd-Jones DM, Carr JJ, Greenland P, Lichtenstein AH, Hu FB, Liu Y, Hou L, Darwish Murad S, Levy D. A Peripheral Blood DNA Methylation Signature of Hepatic Fat Reveals a Potential Causal Pathway for Nonalcoholic Fatty Liver Disease. Diabetes. 2019 05; 68(5):1073-1083.View Related Profiles.

Liu, Chunyu
Long, Michelle

PMID: 30936141

Mukthinuthalapati VVPK, Akinyeye S, Fricker ZP, Syed M, Orman ES, Nephew L, Vilar-Gomez E, Slaven J, Chalasani N, Balakrishnan M, Long MT, Attar BM, Ghabril M. Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitals. PLoS One. 2019; 14(3):e0211811.View Related Profiles.

Long, Michelle
Fricker, Zachary

PMID: 30840670

Hennein R, Liu C, McKeown NM, Hoffmann U, Long MT, Levy D, Ma J. Increased Diet Quality is Associated with Long-Term Reduction of Abdominal and Pericardial Fat. Obesity (Silver Spring). 2019 04; 27(4):670-677.View Related Profiles.

Liu, Chunyu
Long, Michelle

PMID: 30825267

Ma J, Nano J, Ding J, Zheng Y, Hennein R, Liu C, Speliotes EK, Huan T, Song C, Mendelson MM, Joehanes R, Long MT, Liang L, Smith JA, Reynolds L, Ghanbari M, Muka T, van Meurs J, Alferink LJM, Franco OH, Dehghan A, Ratliff S, Zhao W, Bielak L, Kardia SL, Peyser PA, Ning H, VanWagner LB, Lloyd-Jones DM, Carr JJ, Greenland P, Lichtenstein AH, Hu FB, Liu Y, Hou L, Murad SD, Levy D. A Peripheral Blood DNA Methylation Signature of Hepatic Fat Reveals a Potential Causal Pathway for Non-Alcoholic Fatty Liver Disease. Diabetes. 2019 Feb 22.View Related Profiles.

Liu, Chunyu
Long, Michelle

PMID: 30796027

Simon TG, Deng X, Liu CT, Chung RT, Long MT. The immunity-related GTPase M rs13361189 variant does not increase the risk for prevalent or incident steatosis; results from the Framingham Heart Study. Liver Int. 2019 06; 39(6):1022-1026.View Related Profiles.

Liu, Ching-Ti
Long, Michelle

PMID: 30597691

Fricker ZP, Pedley A, Massaro JM, Vasan RS, Hoffmann U, Benjamin EJ, Long MT. Liver Fat Is Associated With Markers of Inflammation and Oxidative Stress in Analysis of Data From the Framingham Heart Study. Clin Gastroenterol Hepatol. 2019 05; 17(6):1157-1164.e4.View Related Profiles.

Benjamin, Emelia
Massaro, Joseph
Long, Michelle
Fricker, Zachary

PMID: 30476583

Long MT, Gurary EB, Massaro JM, Ma J, Hoffmann U, Chung RT, Benjamin EJ, Loomba R. Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring. Liver Int. 2019 04; 39(4):740-747.View Related Profiles.

Benjamin, Emelia
Massaro, Joseph
Long, Michelle

PMID: 30179294

Tran AN, Sachdev R, Fricker ZP, Leber M, Zahorian T, Shah B, Nunes DP, Long MT. Intensive Pharmacy Care Improves Outcomes of Hepatitis C Treatment in a Vulnerable Patient Population at a Safety-Net Hospital. Dig Dis Sci. 2018 12; 63(12):3241-3249.View Related Profiles.

Nunes, David
Long, Michelle
Fricker, Zachary

PMID: 30078116

Ma J, Hennein R, Liu C, Long MT, Hoffmann U, Jacques PF, Lichtenstein AH, Hu FB, Levy D. Improved Diet Quality Associates With Reduction in Liver Fat, Particularly in Individuals With High Genetic Risk Scores for Nonalcoholic Fatty Liver Disease. Gastroenterology. 2018 07; 155(1):107-117.View Related Profiles.

Liu, Chunyu
Long, Michelle

PMID: 29604292

Long MT, Pedley A, Massaro JM, Hoffmann U, Ma J, Loomba R, Chung RT, Benjamin EJ. A simple clinical model predicts incident hepatic steatosis in a community-based cohort: The Framingham Heart Study. Liver Int. 2018 08; 38(8):1495-1503.View Related Profiles.

Benjamin, Emelia
Massaro, Joseph
Long, Michelle

PMID: 29377504

Lee JJ, Pedley A, Hoffmann U, Massaro JM, Levy D, Long MT. Visceral and Intrahepatic Fat Are Associated with Cardiometabolic Risk Factors Above Other Ectopic Fat Depots: The Framingham Heart Study. Am J Med. 2018 06; 131(6):684-692.e12.View Related Profiles.

Massaro, Joseph
Long, Michelle

PMID: 29518370

Long MT, Benjamin EJ. Prevalent Cardiovascular Disease Events and T1 Mapping Defined Hepatic Fibrosis. Circ Cardiovasc Imaging. 2018 03; 11(3):e007553.View Related Profiles.

Benjamin, Emelia
Long, Michelle

PMID: 29523556

Datta S, Sherva RM, De La Cruz M, Long MT, Roy P, Backman V, Chowdhury S, Roy HK. Single Nucleotide Polymorphism Facilitated Down-Regulation of the Cohesin Stromal Antigen-1: Implications for Colorectal Cancer Racial Disparities. Neoplasia. 2018 03; 20(3):289-294.View Related Profiles.

Roy, Hemant
Long, Michelle
Sherva, Richard
Chowdhury, Sanjib
Datta, Somenath

PMID: 29471289; DOI: 10.1016/j.neo.2018.01.003;

Shah RV, Yeri AS, Murthy VL, Massaro JM, D'Agostino R, Freedman JE, Long MT, Fox CS, Das S, Benjamin EJ, Vasan RS, O'Donnell CJ, Hoffmann U. Association of Multiorgan Computed Tomographic Phenomap With Adverse Cardiovascular Health Outcomes: The Framingham Heart Study. JAMA Cardiol. 2017 11 01; 2(11):1236-1246.View Related Profiles.

O'Donnell, Christopher
Benjamin, Emelia
Long, Michelle
D'Agostino, Ralph
Ramachandran, Vasan

PMID: 28975197

O'Sullivan JF, Morningstar JE, Yang Q, Zheng B, Gao Y, Jeanfavre S, Scott J, Fernandez C, Zheng H, O'Connor S, Cohen P, Vasan RS, Long MT, Wilson JG, Melander O, Wang TJ, Fox C, Peterson RT, Clish CB, Corey KE, Gerszten RE. Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetes. J Clin Invest. 2017 12 01; 127(12):4394-4402.View Related Profiles.

Long, Michelle
Yang, Qiong
Ramachandran, Vasan

PMID: 29083323

Lee JJ, Pedley A, Hoffmann U, Massaro JM, O'Donnell CJ, Benjamin EJ, Long MT. Longitudinal Associations of Pericardial and Intrathoracic Fat With Progression of Coronary Artery Calcium (from the Framingham Heart Study). Am J Cardiol. 2018 01 15; 121(2):162-167.View Related Profiles.

O'Donnell, Christopher
Benjamin, Emelia
Massaro, Joseph
Long, Michelle

PMID: 29146023

Li W, Dorans KS, Wilker EH, Rice MB, Long MT, Schwartz J, Coull BA, Koutrakis P, Gold DR, Fox CS, Mittleman MA. Residential Proximity to Major Roadways, Fine Particulate Matter, and Hepatic Steatosis: The Framingham Heart Study. Am J Epidemiol. 2017 Oct 01; 186(7):857-865. PMID: 28605427

Kimberly WT, O'Sullivan JF, Nath AK, Keyes M, Shi X, Larson MG, Yang Q, Long MT, Vasan R, Peterson RT, Wang TJ, Corey KE, Gerszten RE. Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitis. JCI Insight. 2017 May 04; 2(9).View Related Profiles.

Larson, Martin
Long, Michelle
Yang, Qiong

PMID: 28469090; DOI: 10.1172/jci.insight.92989;

Long MT, Yin X, Larson MG, Ellinor PT, Lubitz SA, McManus DD, Magnani JW, Staerk L, Ko D, Helm RH, Hoffmann U, Chung RT, Benjamin EJ. Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart Study. J Am Heart Assoc. 2017 May 02; 6(5).View Related Profiles.

Ko, Darae
Benjamin, Emelia
Larson, Martin
Long, Michelle
Helm, Robert

PMID: 28465298; DOI: 10.1161/JAHA.116.005227;

Lee JJ, Pedley A, Therkelsen KE, Hoffmann U, Massaro JM, Levy D, Long MT. Upper Body Subcutaneous Fat Is Associated with Cardiometabolic Risk Factors. Am J Med. 2017 Aug; 130(8):958-966.e1.View Related Profiles.

Massaro, Joseph
Long, Michelle

PMID: 28238696; DOI: 10.1016/j.amjmed.2017.01.044;

Shao D, Han J, Hou X, Fry J, Behring JB, Seta F, Long MT, Roy HK, Cohen RA, Matsui R, Bachschmid MM. Glutaredoxin-1 Deficiency Causes Fatty Liver and Dyslipidemia by Inhibiting Sirtuin-1. Antioxid Redox Signal. 2017 Aug 20; 27(6):313-327.View Related Profiles.

Shao, Di
Seta, Francesca
Roy, Hemant
Behring, Jessica
Fry, Jessica
Han, Jingyan
Bachschmid, Markus
Long, Michelle
Matsui, Reiko
Cohen, Richard

PMID: 27958883; DOI: 10.1089/ars.2016.6716;

Ma J, Hwang SJ, Pedley A, Massaro JM, Hoffmann U, Chung RT, Benjamin EJ, Levy D, Fox CS, Long MT. Bi-directional analysis between fatty liver and cardiovascular disease risk factors. J Hepatol. 2017 Feb; 66(2):390-397.View Related Profiles.

Benjamin, Emelia
Massaro, Joseph
Long, Michelle
Hwang, Shih-Jen

PMID: 27729222; DOI: 10.1016/j.jhep.2016.09.022;

Ko D, Riles EM, Marcos EG, Magnani JW, Lubitz SA, Lin H, Long MT, Schnabel RB, McManus DD, Ellinor PT, Ramachandran VS, Wang TJ, Gerszten RE, Benjamin EJ, Yin X, Rienstra M. Metabolomic Profiling in Relation to New-Onset Atrial Fibrillation (from the Framingham Heart Study). Am J Cardiol. 2016 Nov 15; 118(10):1493-1496.View Related Profiles.

Ko, Darae
Benjamin, Emelia
Lin, Honghuang
Long, Michelle
Ramachandran, Vasan

PMID: 27666170; DOI: 10.1016/j.amjcard.2016.08.010;

Cui J, Chen CH, Lo MT, Schork N, Bettencourt R, Gonzalez MP, Bhatt A, Hooker J, Shaffer K, Nelson KE, Long MT, Brenner DA, Sirlin CB, Loomba R, For The Genetics Of Nafld In Twins Consortium. Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin study. Hepatology. 2016 Nov; 64(5):1547-1558. PMID: 27315352; DOI: 10.1002/hep.28674;

Long MT, Pedley A, Massaro JM, Hoffmann U, Fox CS. The Association between Non-Invasive Hepatic Fibrosis Markers and Cardiometabolic Risk Factors in the Framingham Heart Study. PLoS One. 2016; 11(6):e0157517.View Related Profiles.

Massaro, Joseph
Long, Michelle

PMID: 27341207; PMCID: PMC4920364; DOI: 10.1371/journal.pone.0157517;

Long MT, Pedley A, Colantonio LD, Massaro JM, Hoffmann U, Muntner P, Fox CS. Development and Validation of the Framingham Steatosis Index to Identify Persons With Hepatic Steatosis. Clin Gastroenterol Hepatol. 2016 Aug; 14(8):1172-1180.e2.View Related Profiles.

Massaro, Joseph
Long, Michelle

PMID: 27046482; PMCID: PMC4955680; DOI: 10.1016/j.cgh.2016.03.034;

Long MT, Fox CS. The Framingham Heart Study--67 years of discovery in metabolic disease. Nat Rev Endocrinol. 2016 Mar; 12(3):177-83. PMID: 26775764; DOI: 10.1038/nrendo.2015.226;

Long MT, Pedley A, Massaro JM, Hoffmann U, Esliger DW, Vasan RS, Fox CS, Murabito JM. Hepatic steatosis is associated with lower levels of physical activity measured via accelerometry. Obesity (Silver Spring). 2015 Jun; 23(6):1259-66.View Related Profiles.

Murabito, Joanne
Massaro, Joseph
Long, Michelle
Ramachandran, Vasan

PMID: 25959049; PMCID: PMC4446168; DOI: 10.1002/oby.21058;

Long MT, Leszczynski A, Thompson KD, Wasan SK, Calderwood AH. Female authorship in major academic gastroenterology journals: a look over 20 years. Gastrointest Endosc. 2015; 81(6):1440-1447.e3.View Related Profiles.

Calderwood, Audrey
Long, Michelle
Wasan, Sharmeel

PMID: 25887727; DOI: 10.1016/j.gie.2015.01.032;

Long MT, Wang N, Larson MG, Mitchell GF, Palmisano J, Vasan RS, Hoffmann U, Speliotes EK, Vita JA, Benjamin EJ, Fox CS, Hamburg NM. Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart study. Arterioscler Thromb Vasc Biol. 2015 May; 35(5):1284-91.View Related Profiles.

Benjamin, Emelia
Vita, Joseph
Larson, Martin
Long, Michelle
Hamburg, Naomi
Ramachandran, Vasan

PMID: 25745056; PMCID: PMC4520415; DOI: 10.1161/ATVBAHA.114.305200;

Long M, Lichtenstein D. Review: in high-risk ulcers, intermittent and continuous PPI therapy do not differ for recurrent bleeding. Ann Intern Med. 2015 Jan 20; 162(2):JC8.View Related Profiles.

Lichtenstein, David
Long, Michelle

PMID: 25599368; DOI: 10.7326/ACPJC-2015-162-2-008;

Rosenquist KJ, Massaro JM, Pedley A, Long MT, Kreger BE, Vasan RS, Murabito JM, Hoffmann U, Fox CS. Fat quality and incident cardiovascular disease, all-cause mortality, and cancer mortality. J Clin Endocrinol Metab. 2015 Jan; 100(1):227-34.View Related Profiles.

Kreger, Bernard
Murabito, Joanne
Massaro, Joseph
Long, Michelle
Ramachandran, Vasan

PMID: 25226289; DOI: 10.1210/jc.2013-4296;

Mendel JB, Long M, Slanetz PJ. CT-guided core needle biopsy of breast lesions visible only on MRI. AJR Am J Roentgenol. 2007 Jul; 189(1):152-4.View Related Profiles.

Long, Michelle
Slanetz, Priscilla

PMID: 17579165

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 49 publications over 7 distinct years, with a maximum of 13 publications in 2019